1. Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper. Issue 10 (October 2022) Authors: Gagelmann, Nico; Sureda, Anna; Montoto, Silvia; Murray, John; Bolaños, Natacha; Kenyon, Michelle; Beksac, Meral; Schönland, Stefan; Hayden, Patrick; Scheurer, Hans; Morgan, Kate; Garderet, Laurent; McLornan, Donal P; Ruggeri, Annalisa Journal: Lancet Issue: Volume 9:Issue 10(2022) Page Start: e786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study. Issue 2 (February 2019) Authors: Bonifazi, Francesca; Solano, Carlos; Wolschke, Christine; Sessa, Mariarosaria; Patriarca, Francesca; Zallio, Francesco; Nagler, Arnon; Selleri, Carmine; Risitano, Antonio Maria; Messina, Giuseppe; Bethge, Wolfgang; Herrera, Pilar; Sureda, Anna; Carella, Angelo Michele; Cimminiello, Michele; Guidi... Journal: Lancet Issue: Volume 6:Issue 2(2019) Page Start: e89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 9980 (9th May 2015) Authors: Moskowitz, Craig H; Nademanee, Auayporn; Masszi, Tamas; Agura, Edward; Holowiecki, Jerzy; Abidi, Muneer H; Chen, Andy I; Stiff, Patrick; Gianni, Alessandro M; Carella, Angelo; Osmanov, Dzhelil; Bachanova, Veronika; Sweetenham, John; Sureda, Anna; Huebner, Dirk; Sievers, Eric L; Chi, Andy; Larsen,... Journal: Lancet Issue: Volume 385:Issue 9980(2015) Page Start: 1853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Brentuximab vedotin for lymphoma in paediatric patients. Issue 10 (October 2018) Authors: Sureda, Anna; Domingo-Domènech, Eva Journal: Lancet Issue: Volume 5:Issue 10(2018) Page Start: e433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study. Issue 2 (February 2019) Authors: Bonifazi, Francesca; Solano, Carlos; Wolschke, Christine; Sessa, Mariarosaria; Patriarca, Francesca; Zallio, Francesco; Nagler, Arnon; Selleri, Carmine; Risitano, Antonio Maria; Messina, Giuseppe; Bethge, Wolfgang; Herrera, Pilar; Sureda, Anna; Carella, Angelo Michele; Cimminiello, Michele; Guidi... Journal: Lancet Issue: Volume 6:Issue 2(2019) Page Start: e89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Handling the COVID-19 pandemic in the oncological setting. Issue 5 (May 2020) Authors: Mussetti, Alberto; Maluquer, Clara; Albasanz-Puig, Adaia; Gudiol, Carlota; Moreno-Gonzalez, Gabriel; Corradini, Paolo; Sureda, Anna Journal: Lancet Issue: Volume 7:Issue 5(2020) Page Start: e365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Mesenchymal stromal cells for steroid-refractory acute GVHD. Issue 1 (January 2016) Authors: Parody, Rocío; Sureda, Anna Journal: Lancet Issue: Volume 3:Issue 1(2016) Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study. Issue 5 (May 2021) Authors: Azoulay, Élie; Castro, Pedro; Maamar, Adel; Metaxa, Victoria; de Moraes, Alice Gallo; Voigt, Louis; Wallet, Florent; Klouche, Kada; Picard, Muriel; Moreau, Anne-Sophie; Van De Louw, Andry; Seguin, Amélie; Mokart, Djamel; Chawla, Sanjay; Leroy, Julien; Böll, Boris; Issa, Nahema; Levy, Bruno; Hemel... Journal: Lancet Issue: Volume 8:Issue 5(2021) Page Start: e355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Second-line CAR T cells for lymphomas. Issue 10343 (18th June 2022) Authors: Mussetti, Alberto; Sureda, Anna Journal: Lancet Issue: Volume 399:Issue 10343(2022) Page Start: 2247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. What's behind chronic graft versus host disease incidence curves?. Issue 2 (February 2020) Authors: Mussetti, Alberto; Sureda, Anna Journal: Lancet Issue: Volume 7:Issue 2(2020) Page Start: e83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗